Document Detail

[Nutrition and Phosphorus - New progress and problem - . Phosphate metabolism and nutritional therapy in predialysis patients].
MedLine Citation:
PMID:  23023639     Owner:  NLM     Status:  In-Data-Review    
Phosphate metabolism is disordered in patients with chronic kidney disease (CKD). Although there is insufficient evidence in predialysis patients, hyperphosphatemia is closely connected with poor prognosis and cardiovascular disease. The standard approaches to management of elevated serum phosphate are dietary restriction and drug treatment using oral phosphate binders. Treatment of hyperphosphatemia is important in patients with CKD. On the other hand, it is possible that dietary restriction causes protein energy wasting (PEW). It is necessary to pay attention to both hyperphosphatemia and PEW in CKD patients.
Yasuhiro Hamada; Makoto Usami
Publication Detail:
Type:  English Abstract; Journal Article    
Journal Detail:
Title:  Clinical calcium     Volume:  22     ISSN:  0917-5857     ISO Abbreviation:  Clin Calcium     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9433326     Medline TA:  Clin Calcium     Country:  Japan    
Other Details:
Languages:  jpn     Pagination:  1577-82     Citation Subset:  IM    
Department of Nutrition, Kobe University Hospital, Kobe University School of Medicine, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  [Cinacalcet hydrochloride and phosphate metabolism].
Next Document:  [Nutrition and Phosphorus - New progress and problem - . Information about phosphorus additives and ...